Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Allied Market Research | PRODUCT CODE: 1040249

Cover Image

PUBLISHER: Allied Market Research | PRODUCT CODE: 1040249

Equine Healthcare Market by Product Type, Disease, and Distribution Channel : Opportunity Analysis and Industry Forecast, 2020-2030

PUBLISHED:
PAGES: 203 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Excel (Data Pack)
USD 4125
PDF (Single User License + Covid impact)
USD 6168
PDF (5-user License)
USD 6929
PDF (Enterprise User License)
USD 10663

Add to Cart

Equine health is an important aspect of a horse's quality of life. Maintaining good health in racehorses is vital as proper management can reduce the incidence of many disease conditions. As horses interact with its environment, it relies on health concerns to maintain proper performance and stability of horses. Understanding the horse's health can help to promote its overall well-being. The healthcare of horses includes routine veterinary care for vaccinations, parasite control, and dental care; grooming and hoof care; and protection.

The global equine healthcare devices market was valued at $1,206.70 million in 2020, and is projected to reach $2,328.90 million by 2030, registering a CAGR of 6.80% from 2021 to 2030, owing to rise in prevalence of equine diseases, increase in equine population, increase in animal health expenditure, rise in demand for use of horses for various purposes, increase in advancements of equine healthcare products, and growing awareness among the population about the importance and benefits of horses healthcare. However, decline in equine population is expected to hamper the market growth.

The global equine healthcare market is segmented into product type, disease, and distribution channel. Based on product type, the market is categorized into drug, vaccines, and medicated feed additives. Furthermore, drugs are classified into anti-infectives, anti-inflammatory, parasiticides, and others. Vaccines are classified into inactivated, live attenuated, recombinant, and others. Based on disease, the market is divided into influenza, tetanus, equine herpes virus, and others (equine encephalomyelitis, west nile virus, equine rabies, and potomac horse fever). On the basis of distribution channel, it is bifurcated into veterinary hospitals and clinics and retail pharmacies and drug stores. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities.
  • An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the hemodialysis and peritoneal dialysis market is provided.
  • An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Product Type

  • Drug
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Others
  • Vaccines
  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others
  • Medicated Feed Additives

By Disease

  • Influenza
  • Tetanus
  • Equine Herpes Virus
  • Others

By Distribution Channel

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

KEY MARKET PLAYERS

  • Thermo Fisher Scientific (Affymetrix)
  • Elanco Animal Health (Bayer Animal Health)
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Land o Lakes (Purina Mills LLC)
  • EQUINE PRODUCTS UK LTD
  • Merck & Co. (Merck Animal Health)
  • Sanofi (Merial)
  • Vetoquinol S.A.
  • Zoetis
Product Code: LI_18387 / A00294

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key Benefits for Stakeholders
  • 1.3.Key market segments
    • 1.3.1.List of key players profiled in the report
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Porter's five force analysis
  • 3.4.Top player positioning, 2020
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in prevalence of equine diseases
      • 3.5.1.2.Rise in animal health expenditure
    • 3.5.2.Restraint
      • 3.5.2.1.Decline in global equine population
    • 3.5.3.Opportunities
      • 3.5.3.1.Rise in demand for pet insurance
    • 3.5.4.Impact analysis
  • 3.6.COVID-19 Impact Analysis on Equine healthcare Market

CHAPTER 4:EQUINE HEALTHCARE MARKET, BY PRODUCT

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Drug
    • 4.2.1.Key market trends, growth factors, and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
    • 4.2.4.Anti-infectives Drugs
      • 4.2.4.1.Market size and forecast
    • 4.2.5.Anti-Inflammatory Drugs
      • 4.2.5.1.Market size and forecast
    • 4.2.6.Parasiticide Drugs
      • 4.2.6.1.Market size and forecast
    • 4.2.7.Other Drugs
      • 4.2.7.1.Market size and forecast
  • 4.3.Vaccines
    • 4.3.1.Key market trends, growth factors, and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country
    • 4.3.4.Inactivated Vaccines
      • 4.3.4.1.Market size and forecast
    • 4.3.5.Live Attenuated Vaccine
      • 4.3.5.1.Market size and forecast
    • 4.3.6.Recombinant Vaccine
      • 4.3.6.1.Market size and forecast
    • 4.3.7.Other vaccines
      • 4.3.7.1.Market size and forecast
  • 4.4.Medicated feed additives
    • 4.4.1.Key market trends, growth factors, and opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market analysis, by country

CHAPTER 5:EQUINE HEALTHCARE MARKET, BY DISEASES

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Influenza
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Tetanus
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Equine Herpes Virus
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Other diseases
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country

CHAPTER 6:EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Veterinary Hospitals and Clinics
    • 6.2.1.Market size and forecast, by region
    • 6.2.2.Market analysis, by country
  • 6.3.Retail pharmacies and Drug Stores
    • 6.3.1.Market size and forecast, by region
    • 6.3.2.Market analysis, by country

CHAPTER 7:EQUINE HEALTHCARE MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
      • 7.2.3.1.U.S.
      • 7.2.3.1.1.U.S. Equine Healthcare market, by product type
      • 7.2.3.1.2.U.S. Equine Healthcare market, by diseases
      • 7.2.3.1.3.U.S. Equine Healthcare market, by distribution channel
      • 7.2.3.2.Canada
      • 7.2.3.2.1.Canada Equine Healthcare market, by product type
      • 7.2.3.2.2.Canada Equine Healthcare market, by diseases
      • 7.2.3.2.3.Canada Equine Healthcare market, by distribution channel
      • 7.2.3.3.Mexico
      • 7.2.3.3.1.Mexico Equine Healthcare market, by product type
      • 7.2.3.3.2.Mexico Equine Healthcare market, by diseases
      • 7.2.3.3.3.Mexico Equine Healthcare market, by distribution channel
    • 7.2.4.North America market size and forecast, by product type
    • 7.2.5.North America market size and forecast, by diseases
    • 7.2.6.North America market size and forecast, by distribution channel
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Market size and forecast, by country
      • 7.3.2.1.Germany
      • 7.3.2.1.1.Germany Equine Healthcare market, by product type
      • 7.3.2.1.2.Germany Equine Healthcare market, by diseases
      • 7.3.2.1.3.Germany Equine Healthcare market, by distribution channel
      • 7.3.2.2.France
      • 7.3.2.2.1.France Equine Healthcare market, by product type
      • 7.3.2.2.2.France Equine Healthcare market, by diseases
      • 7.3.2.2.3.France Equine Healthcare market, by distribution channel
      • 7.3.2.3.UK
      • 7.3.2.3.1.UK Equine Healthcare market, by product type
      • 7.3.2.3.2.UK Equine Healthcare market, by diseases
      • 7.3.2.3.3.UK Equine Healthcare market, by distribution channel
      • 7.3.2.4.Italy
      • 7.3.2.4.1.Italy Equine Healthcare market, by product type
      • 7.3.2.4.2.Italy Equine Healthcare market, by diseases
      • 7.3.2.4.3.Italy Equine Healthcare market, by distribution channel
      • 7.3.2.5.Spain
      • 7.3.2.5.1.Spain Equine Healthcare market, by product type
      • 7.3.2.5.2.Spain Equine Healthcare market, by diseases
      • 7.3.2.5.3.Spain Equine Healthcare market, by distribution channel
      • 7.3.2.6.Rest of Europe
      • 7.3.2.6.1.Rest of Europe Equine Healthcare market, by product type
      • 7.3.2.6.2.Rest of Europe Equine Healthcare market, by diseases
      • 7.3.2.6.3.Rest of Europe Equine Healthcare market, by distribution channel
    • 7.3.3.Europe market size and forecast, by product type
    • 7.3.4.Europe market size and forecast, by diseases
    • 7.3.5.Europe market size and forecast, by distribution channel
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Market size and forecast, by country
      • 7.4.2.1.Japan
      • 7.4.2.1.1.Japan Equine Healthcare market, by product type
      • 7.4.2.1.2.Japan Equine Healthcare market, by diseases
      • 7.4.2.1.3.Japan Equine Healthcare market, by distribution channel
      • 7.4.2.2.China
      • 7.4.2.2.1.China Equine Healthcare market, by product type
      • 7.4.2.2.2.China Equine Healthcare market, by diseases
      • 7.4.2.2.3.China Equine Healthcare market, by distribution channel
      • 7.4.2.3.Australia
      • 7.4.2.3.1.Australia Equine Healthcare market, by product type
      • 7.4.2.3.2.Australia Equine Healthcare market, by diseases
      • 7.4.2.3.3.Australia Equine Healthcare market, by distribution channel
      • 7.4.2.4.India
      • 7.4.2.4.1.India Equine Healthcare market, by product type
      • 7.4.2.4.2.India Equine Healthcare market, by diseases
      • 7.4.2.4.3.India Equine Healthcare market, by distribution channel
      • 7.4.2.5.South Korea
      • 7.4.2.5.1.South Korea Equine Healthcare market, by product type
      • 7.4.2.5.2.South Korea Equine Healthcare market, by diseases
      • 7.4.2.5.3.South Korea Equine Healthcare market, by distribution channel
      • 7.4.2.6.Rest of Asia-Pacific
      • 7.4.2.6.1.Rest of Asia-Pacific Equine Healthcare market, by product type
      • 7.4.2.6.2.Rest of Asia-Pacific Equine Healthcare market, by diseases
      • 7.4.2.6.3.Rest of Asia-Pacific Equine Healthcare market, by distribution channel
    • 7.4.3.Asia-Pacific market size and forecast, by product type
    • 7.4.4.Asia-Pacific market size and forecast, by diseases
    • 7.4.5.Asia-Pacific market size and forecast, by distribution channel
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.Market size and forecast, by country
      • 7.5.2.1.Brazil
      • 7.5.2.1.1.Brazil Equine Healthcare market, by product type
      • 7.5.2.1.2.Brazil Equine Healthcare market, by diseases
      • 7.5.2.1.3.Brazil Equine Healthcare market, by distribution channel
      • 7.5.2.2.Saudi Arabia
      • 7.5.2.2.1.Saudi Arabia Equine Healthcare market, by product type
      • 7.5.2.2.2.Saudi Arabia Equine Healthcare market, by diseases
      • 7.5.2.2.3.Saudi Arabia Equine Healthcare market, by distribution channel
      • 7.5.2.3.South Africa
      • 7.5.2.3.1.South Africa Equine Healthcare market, by product type
      • 7.5.2.3.2.South Africa Equine Healthcare market, by diseases
      • 7.5.2.3.3.South Africa Equine Healthcare market, by distribution channel
      • 7.5.2.4.Rest of LAMEA
      • 7.5.2.4.1.Rest of LAMEA Equine Healthcare market, by product type
      • 7.5.2.4.2.Rest of LAMEA Equine Healthcare market, by diseases
      • 7.5.2.4.3.Rest of LAMEA Equine Healthcare market, by distribution channel
    • 7.5.3.LAMEA market size and forecast, by product type
    • 7.5.4.LAMEA market size and forecast, by diseases
    • 7.5.5.LAMEA market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

  • 8.1.Boehringer Ingelheim International GmbH
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Key strategic moves and developments
  • 8.2.Ceva Sante Animale
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
    • 8.2.4.Product portfolio
  • 8.3.Elanco Animal Health Inc. (Bayer Animal Health)
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.Equine Products UK LTD
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
    • 8.4.5.Key strategic moves and developments
  • 8.5.Land O'Lakes, Inc. (Purina Mills, LLC)
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
  • 8.6.MERCK & CO., INC.(Merck Animal Health)
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
    • 8.6.5.Business performance
  • 8.7.Sanofi S.A. (Merial)
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
    • 8.7.5.Business performance
  • 8.8.Thermo Fisher Scientific Inc. (Affymetrix Inc.)
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
  • 8.9.Vetoquinol S.A.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
  • 8.10.Zoetis Inc.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
    • 8.10.6.Key strategic moves and developments
Product Code: LI_18387 / A00294

LIST OF TABLES

  • TABLE 01.EQUINE HEALTHCARE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 02.EQUINE HEALTHCARE MARKET FOR DRUGS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 03.EQUINE HEALTHCARE MARKET FOR VACCINES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 04.EQUINE HEALTHCARE MARKET FOR MEDICATED FEED ADDITVES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 05.EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 06.EQUINE HEALTHCARE MARKET FOR INFLUENZA, BY REGION, 2020-2030 ($MILLION)
  • TABLE 07.EQUINE HEALTHCARE MARKET FOR TETANUS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 08.EQUINE HEALTHCARE MARKET FOR EQUINE HERPES VIRUS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 09.EQUINE HEALTHCARE MARKET FOR OTHER DISEASES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 11.EQUINE HEALTHCARE MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.EQUINE HEALTHCARE MARKET FOR RETAIL PHARMACIES AND DRUG STORES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 13.EQUINE HEALTHCARE MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.U.S. EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 17.U.S. EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 18.U.S. EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 19.CANADA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 20.CANADA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 21.CANADA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 22.MEXICO EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 23.MEXICO EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 24.MEXICO EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 25.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 26.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 27.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 28.EUROPE EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 29.GERMANY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 30.GERMANY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 31.GERMANY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 32.FRANCE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 33.FRANCE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 34.FRANCE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 35.UK EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 36.UK EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 37.UK EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 38.ITALY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 39.ITALY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 40.ITALY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 41.SPAIN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 42.SPAIN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 43.SPAIN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 44.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 45.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 46.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 47.EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 48.EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 49.EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 50.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 51.JAPAN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 52.JAPAN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 53.JAPAN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 54.CHINA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 55.CHINA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 56.CHINA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 57.AUSTRALIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 58.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 59.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 60.INDIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 61.INDIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 62.INDIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 63.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 64.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 65.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 66.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 67.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 68.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 69.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 70.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 71.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 72.LAMEA EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 73.BRAZIL EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 74.BRAZIL EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 75.BRAZIL EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 76.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 77.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 78.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 79.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 80.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 81.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 82.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 83.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 84.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 85.LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
  • TABLE 86.LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
  • TABLE 87.LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
  • TABLE 88.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • TABLE 89.BOEHRINGER INGELHEIM: OPERATING SEGMENTS
  • TABLE 90.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
  • TABLE 91.BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92.CEVA SANTE: COMPANY SNAPSHOT
  • TABLE 93.CEVA SANTE: OERATING SEGMENT
  • TABLE 94.CEVA SANTE: PRODUCT PORTFOLIO
  • TABLE 95.ELANCO: COMPANY SNAPSHOT
  • TABLE 96.ELANCO: OPERATING SEGMENTS
  • TABLE 97.ELANCO: PRODUCT PORTFOLIO
  • TABLE 98.ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99.EQUINE PRODUCTS: COMPANY SNAPSHOT
  • TABLE 100.EQUINE PRODUCTS: OPERATING SEGMENTS
  • TABLE 101.EQUINE PRODUCTS: PRODUCT PORTFOLIO
  • TABLE 102.EQUINE PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103.LAND O'LAKES: COMPANY SNAPSHOT
  • TABLE 104.LAND O'LAKES: OPERATING SEGMENTS
  • TABLE 105.LAND O'LAKES: PRODUCT PORTFOLIO
  • TABLE 106.MERCK: COMPANY SNAPSHOT
  • TABLE 107.MERCK: OPERATING SEGMENTS
  • TABLE 108.MERCK: PRODUCT PORTFOLIO
  • TABLE 109.SANOFI: COMPANY SNAPSHOT
  • TABLE 110.SANOFI: OERATING SEGMENT
  • TABLE 111.SANOFI: PRODUCT PORTFOLIO
  • TABLE 112.THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 113.THERMO FISHER SCIENTIFIC: OERATING SEGMENT
  • TABLE 114.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 115.VETOQUINOL: COMPANY SNAPSHOT
  • TABLE 116.VETOQUINOL: OPERATING SEGMENTS
  • TABLE 117.VETOQUINOL: PRODUCT PORTFOLIO
  • TABLE 118.ZOETIS: COMPANY SNAPSHOT
  • TABLE 119.ZOETIS: OPERATING SEGMENTS
  • TABLE 120.ZOETIS: PRODUCT PORTFOLIO
  • TABLE 121.ZOETIS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 01.GLOBAL EQUINE HEALTHCARE MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
  • FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 03.HIGH THREAT OF SUBSTITUTES
  • FIGURE 04.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 05.HIGH INTENSITY OF RIVALRY
  • FIGURE 06.TOP PLAYER POSITIONING, 2020
  • FIGURE 07.IMPACT ANALYSIS
  • FIGURE 08.COMPARATIVE ANALYSIS OF DRUGS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 09.ANTI-INFECTIVES DRUGS, 2020-2030, ($MILLION)
  • FIGURE 10.ANTI-INFLAMMATORY DRUGS MARKET, 2020-2030, ($MILLION)
  • FIGURE 11.PARASITICIDE DRUGS MARKET, 2020-2030, ($MILLION)
  • FIGURE 12.OTHER DRUGS MARKET, 2020-2030, ($MILLION)
  • FIGURE 13.COMPARATIVE ANALYSIS OF VACCINES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 ($MILLION)
  • FIGURE 14.INACTIVATED VACCINES MARKET, 2020-2030, ($MILLION)
  • FIGURE 15.LIVE ATTENUATED VACCINE MARKET, 2020-2030, ($MILLION)
  • FIGURE 16.RECOMBINANT VACCINE MARKET, 2020-2030, ($MILLION)
  • FIGURE 17.OTHER VACCINE MARKET, 2020-2030, ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF MEDICATED FEED ADDITIVES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF INFLUENZA EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 20.COMPARATIVE ANALYSIS OF TETANUS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 21.COMPARATIVE ANALYSIS OF EQUINE HERPES VIRUS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 22.COMPARATIVE ANALYSIS OF OTHER DISEASES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 (%)
  • FIGURE 23.COMPARATIVE ANALYSIS OF VETERINARY HOSPITALS AND CLINICS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 24.COMPARATIVE ANALYSIS OF RETAIL PHARMACIES AND DRUG STORES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
  • FIGURE 25.ELANCO: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 26.ELANCO: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 27.MERCK: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 28.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 29.MERCK: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 30.SANOFI: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 31.SANOFI: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.SANOFI: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 33.THERMO FISHER SCIENTIFIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 34.THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 35.THERMO FISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 36.VETOQUINOL: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 37.ZOETIS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.ZOETIS: REVENUE SHARE BY REGION, 2020 (%)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!